Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis

Betül Çiğdem Yortanlı; Hüseyin Mutlu; Burak Kocaoğlu; Ekrem Taha Sert; Kamil Kokulu; Ramiz Yazıcı; Mehmet Yortanlı

doi:10.47582/jompac.1868615

Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis

Abstract

Aims: This study aimed to evaluate the prognostic performance of the age–male–albumin–bilirubin–platelet (aMAP) score in predicting 28-day mortality among patients with acute pancreatitis (AP) presenting to the emergency department (ED). Methods: We retrospectively analyzed adult patients diagnosed with AP between January 2020 and December 2024 in a tertiary ED. Demographic characteristics, laboratory findings, clinical parameters, and mortality outcomes were recorded. aMAP scores were calculated using a validated formula. The prognostic performance of the aMAP score was compared with that of ALBI, BISAP, SOFA, and lactate levels using logistic regression and ROC curve analysis. Results: A total of 386 patients were included in the analysis. The median age was significantly higher among non-survivors than survivors (77 vs. 60 years, p<0.001). Levels of aMAP, ALBI, BISAP, SOFA, and lactate were all significantly higher in the non survivor group (p<0.001 for all). In multivariate logistic regression analysis, aMAP (OR: 4.63; 95% CI: 1.50–14.32; p=0.008) and lactate (OR: 1.62; 95% CI: 1.12–2.33; p=0.010) emerged as independent predictors of mortality. ROC analysis demonstrated that lactate had the highest prognostic accuracy (AUC: 0.843), followed by aMAP (AUC: 0.821) and ALBI (AUC: 0.764). Conclusion: These findings indicate that the aMAP score is a simple, accessible, and effective tool for early mortality risk stratification in patients with AP. Its ease of calculation and prognostic performance comparable to traditional scoring systems support its practical use in the emergency setting.

Keywords

Supporting Institution

None.

Ethical Statement

This study was approved by the Aksaray University Scientific Research Ethics Committee for Health Sciences (Date: 14.02.2025, Decision No: 2025/35, Protocol No: SAGETİK 2025-13). All procedures were conducted in accordance with the ethical principles of the Declaration of Helsinki.

Thanks

None.

References

Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325:382-390. doi:10.1001/jama.2020.20317
Raraty M, Ward J, Erdemli G, et al. Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A. 2000;97(24):13126-13131. doi:10.1073/pnas.97.24.13126
Güzel YE, Çolak N, Okuv AC, Teymuroğlu S, Teke Mİ. Comparing prognostic scoring systems in acute pancreatitis: Bedside Index of Severity in Acute Pancreatitis, WL, and Chinese Simple Scoring System Scores. Turk J Emerg Med. 2024;24(3):165-171. doi:10.4103/tjem.tjem_14_24
Barreto SG, Habtezion A, Gukovskaya A, et al. Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis. Gut. 2021;70(1):194-203. doi:10.1136/gutjnl-2020-322163
Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg. 2002;89(3):298-302. doi:10.1046/j.0007-1323.2001.02025.x
Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: management of acute pancreatitis. Am J Gastroenterol. 2024;119(3):419-437. doi:10.14309/ajg.0000000000002645
Wang L, Zeng YB, Chen JY, et al. A simple new scoring system for predicting the mortality of severe acute pancreatitis. Medicine (Baltimore). 2020;99(23):e20646. doi:10.1097/MD.0000000000020646
Zhou H, Mei X, He X, Lan T, Guo S. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: a retrospective study. Medicine (Baltimore). 2019;98:e15275. doi:10.1097/MD.0000000000015275

Zhang J, Shahbaz M, Fang R, et al. Comparison of the BISAP scores for predicting the severity of acute pancreatitis in Chinese patients according to the latest Atlanta classification. J Hepato-Biliary-Pancreat Sci. 2014;21(9):689-694. doi:10.1002/jhbp.118
Arif A, Jaleel F, Rashid K. Accuracy of BISAP score in prediction of severe acute pancreatitis. Pak J Med Sci. 2019;35(4):1008-1012. doi:10. 12669/pjms.35.4.1286
Mounzer R, Langmead CJ, Wu BU, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142(7):1476-1482. doi:10.1053/j.gastro.2012.03.005
Fan R, Papatheodoridis G, Sun J, et al. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. J Hepatol. 2020;73(6):1368-1378. doi:10.1016/j.jhep.2020.07.025
Yang Y, Zhou Y, Zhang X, et al. Using the aMAP risk score to predict late recurrence following radiofrequency ablation for hepatocellular carcinoma in chinese population: a multicenter study. J Hepatocell Carcinoma. 2021;8:837-850. doi:10.2147/JHC.S308587
Sun Y, Li Z, Liao G, et al. aMAP score as a predictor for long-term outcomes in patients with HBV-related acute-on-chronic liver failure. Int J Gen Med. 2022;15:407-415. doi:10.2147/IJGM.S343457
Lee CH, You GR, Jo HG, et al. Albumin-bilirubin grade as a valuable predictor of recurrence and prognosis in patients with hepatocellular carcinoma following radiofrequency ablation. Cancers. 2024;16(24):4167. doi:10.3390/cancers16244167
Shi L, Zhang D, Zhang J. Albumin-bilirubin score is associated with in-hospital mortality in critically ill patients with acute pancreatitis. Eur J Gastroenterol Hepatol. 2020;32(8):963-970. doi:10.1097/MEG. 0000000000001753
Peery AF, Murphy CC, Anderson C, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2024. Gastroenterology. 2025;168(5):1000-1024. doi:10.1053/j.gastro.2024.12.029
Xiao AY, Tan MLY, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45-55. doi:10.1016/S2468-1253(16)30004-8
Wall I, Badalov N, Baradarian R, Iswara K, Li JJ, Tenner S. Decreased mortality in acute pancreatitis related to early aggressive hydration. Pancreas. 2011;40(4):547-550. doi:10.1097/MPA.0b013e318215368d
Xin Y, Zhang X, Yang Y, et al. Prediction of late recurrence after radiofrequency ablation of HBV-related hepatocellular carcinoma with the age-male-albumin-bilirubin-platelets (aMAP) risk score: a multicenter study. J Gastrointest Oncol. 2021;12(6):2930-2942. doi:10. 21037/jgo-21-506
Chen L, Liu Q, Tan C, et al. The age-male-albumin-bilirubin-platelets (aMAP) risk score predicts liver metastasis following surgery for breast cancer in Chinese population: a retrospective study. Immuno Targets Ther. 2024;13:75-94. doi:10.2147/ITT.S446545
Elgenidy A, Abubasheer TM, Odat RM, et al. Assessing the predictive accuracy of the aMAP risk score for hepatocellular carcinoma (HCC): diagnostic test accuracy and meta-analysis. J Clin Exp Hepatol. 2025; 15(1):102381. doi:10.1016/j.jceh.2024.102381
Fan R, Li G, Yu N, et al. aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in chronic hepatitis B patients. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023;21(12):3070-3079.e13. doi:10.1016/j.cgh.2023.03.005
Fan R, Yu N, Li G, et al. Machine-learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD-related liver fibrosis. Liver Int Off J Int Assoc Study Liver. 2024; 44(3):749-759. doi:10.1111/liv.15818
Chandra S, Murali A, Bansal R, Agarwal D, Holm A. The Bedside Index for Severity in Acute Pancreatitis: a systematic review of prospective studies to determine predictive performance. J Community Hosp Intern Med Perspect. 2017;7(4):208-213. doi:10.1080/20009666.2017.1361292
Sakin A, Sahin S, Sakin A, et al. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis. J BUON Off J Balk Union Oncol. 2020;25(4):1941-1946.
Jiang X, Su Z, Wang Y, et al. Prognostic nomogram for acute pancreatitis patients: an analysis of publicly electronic healthcare records in intensive care unit. J Crit Care. 2019;50:213-220. doi:10.1016/j.jcrc.2018.10.030
Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57(12):1698-1703. doi:10.1136/gut.2008.152702
Ye JF, Zhao YX, Ju J, Wang W. Building and verifying a severity prediction model of acute pancreatitis (AP) based on BISAP, MEWS and routine test indexes. Clin Res Hepatol Gastroenterol. 2017;41(5):585-591. doi:10.1016/j.clinre.2016.11.013

Details

Primary Language

English

Subjects

Emergency Medicine, Gastroenterology and Hepatology, Internal Diseases

Journal Section

Research Article

Authors

Betül Çiğdem Yortanlı ^*
0000-0003-2698-3159
Türkiye

Hüseyin Mutlu
0000-0002-1930-3293
Türkiye

Burak Kocaoğlu
0009-0009-7348-6973
Türkiye

Ekrem Taha Sert
0000-0002-7208-2186
Türkiye

Kamil Kokulu
0000-0002-6132-0898
Türkiye

Ramiz Yazıcı
0000-0001-9210-914X
Türkiye

Mehmet Yortanlı
0000-0002-6744-2423
Türkiye

Publication Date

February 20, 2026

Submission Date

January 21, 2026

Acceptance Date

February 16, 2026

Published in Issue

Year 2026 Volume: 7 Number: 1

DOI

https://doi.org/10.47582/jompac.1868615

IZ

https://izlik.org/JA84LH38KY

Cite

RIS / Bibtex

APA

Yortanlı, B. Ç., Mutlu, H., Kocaoğlu, B., Sert, E. T., Kokulu, K., Yazıcı, R., & Yortanlı, M. (2026). Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis. Journal of Medicine and Palliative Care, 7(1), 168-174. https://doi.org/10.47582/jompac.1868615

AMA

1.Yortanlı BÇ, Mutlu H, Kocaoğlu B, et al. Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis. J Med Palliat Care / JOMPAC / jompac. 2026;7(1):168-174. doi:10.47582/jompac.1868615

Chicago

Yortanlı, Betül Çiğdem, Hüseyin Mutlu, Burak Kocaoğlu, et al. 2026. “Age-Male-Albumin-Bilirubin-Platelet (aMAP) Score As a Predictor of 28-Day Mortality in Acute Pancreatitis”. Journal of Medicine and Palliative Care 7 (1): 168-74. https://doi.org/10.47582/jompac.1868615.

EndNote

Yortanlı BÇ, Mutlu H, Kocaoğlu B, Sert ET, Kokulu K, Yazıcı R, Yortanlı M (February 1, 2026) Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis. Journal of Medicine and Palliative Care 7 1 168–174.

IEEE

[1]B. Ç. Yortanlı et al., “Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis”, J Med Palliat Care / JOMPAC / jompac, vol. 7, no. 1, pp. 168–174, Feb. 2026, doi: 10.47582/jompac.1868615.

ISNAD

Yortanlı, Betül Çiğdem - Mutlu, Hüseyin - Kocaoğlu, Burak - Sert, Ekrem Taha - Kokulu, Kamil - Yazıcı, Ramiz - Yortanlı, Mehmet. “Age-Male-Albumin-Bilirubin-Platelet (aMAP) Score As a Predictor of 28-Day Mortality in Acute Pancreatitis”. Journal of Medicine and Palliative Care 7/1 (February 1, 2026): 168-174. https://doi.org/10.47582/jompac.1868615.

JAMA

1.Yortanlı BÇ, Mutlu H, Kocaoğlu B, Sert ET, Kokulu K, Yazıcı R, Yortanlı M. Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis. J Med Palliat Care / JOMPAC / jompac. 2026;7:168–174.

MLA

Yortanlı, Betül Çiğdem, et al. “Age-Male-Albumin-Bilirubin-Platelet (aMAP) Score As a Predictor of 28-Day Mortality in Acute Pancreatitis”. Journal of Medicine and Palliative Care, vol. 7, no. 1, Feb. 2026, pp. 168-74, doi:10.47582/jompac.1868615.

Vancouver

1.Betül Çiğdem Yortanlı, Hüseyin Mutlu, Burak Kocaoğlu, Ekrem Taha Sert, Kamil Kokulu, Ramiz Yazıcı, Mehmet Yortanlı. Age-male-albumin-bilirubin-platelet (aMAP) score as a predictor of 28-day mortality in acute pancreatitis. J Med Palliat Care / JOMPAC / jompac. 2026 Feb. 1;7(1):168-74. doi:10.47582/jompac.1868615